Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus

PHASE3CompletedINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Subjective Tinnitus
Interventions
DRUG

Neramexane mesylate

Double-blind treatment period of 17 weeks up to 75 mg Neramexane mesylate per day

DRUG

Placebo

Double-blind treatment period of 17 weeks placebo

Trial Locations (54)

10117

Charité, Universitätsmedizin Berlin-Tinnituszentrum, Berlin

13125

Klin. Forschung Berlin Buch GmbH, Berlin

23700

Hospital Comarcal San Agustin, Linares, Jaén

28035

Hospital Puerta del Hierro, Madrid- Servicio de OR, Madrid

28805

Hospital Universitario Príncipe de Asturias, Madrid

28922

Fundación Hospital de Alcorcón, Otorhinolaryngology, Alcorcón - Madrid

31008

Clínica Universitaria de Navarra, Dept. ORL, Pamplona

36381

Dr. Norbert Staab, Schlüchtern

37007

Hospital Universitario de Salamanca- Hospital Virgen de la Vega, Salamanca

38100

Dr. med. Frank Reintjes, Braunschweig

39104

ClinPharm International, Magdeburg

41005

Hospital Universitario Virgen del Rocio- Centro de Especialidades Dr. Fleming, Seville

42579

Dr. Werner Gieselmann, Heiligenhaus

46520

Hospital Sagunto, Sagunto

47179

HNO-Praxis im Gesundheitszentrum Walsum, Duisburg

48716

HNO Gemeinschaftpraxis, Meppen

52074

Dr. med. Nobert Pasch, Aachen

58642

Dr. Wolfgang Lotte, Iserlohn

60596

ClinPharm International GmbH, Frankfurt

64283

Dr. Klaus Peter Jayme, Darmstadt

64653

Dr. Dannesberger, Lorsch

65183

Dr. Hannelore Neumaier, Wiesbaden

67547

Dr. med. Stephanie Göbel, Worms

86199

Dr. Peter Küppers, Augsburg

90402

Dr. med. Ulrike Walter, Nuremberg

90443

Dr. Susanne Wiedemann, Nuremberg

96215

HNO Praxis, Lichtenfels

A-8020

Krankenhaus der Elisabethinen, Graz

A-6330

Bezirkskrankenhaus Kufstein, Kufstein

A-4010

A. ö. Krankenhaus der Elisabethinen Linz, Linz

A-5020

Salzburger Landeskrankenhaus, Universitätsklinik für Hals-Nasen-Ohren-Krankheiten, Salzburg

A-1090

Clin Pharm International GmbH, Zentrum Wien, Vienna

06112

Dr. Elisabeth Kühne, Halle

09120

ClinPharm International, Chemnitz

01277

Dr. Christian Dörr, Dresden

02826

ClinPharm International GmbH, Görlitz

04103

ClinPharm International GmbH, Leipzig

Unknown

LMU München Klinik Großhadern, Munich

Clinica Clivina, Private Consultancy, Jaén

Hospital Xeral-Calde, Lugo

4050-113

Hospital Militar Regional nº 1 Serviço de Otorrinolaringologia, Porto

4050-115

Clínica ORL Dr. Eurico de Almeida, Porto

08036

Hospital Clínico Barcelona, Dept. Of ORL, Barcelona

07004

Hospital Universtiario Son Dureta, Palma de Mallorca

BA2 3HT

Oldfield Surgery, Bath

S40 4TF

Avondale Surgery Research office, Chesterfield

KT24 6QT

The Horsley Medical Practice, East Horsley, Leatherhead, Surrey

LE1 5WW

The university Hospitals of Leicester, Leicester Royal Infirmary, Leicester

LE10 2SE

Burbage Surgery, Leicestershire

NE7 7DN

The Freeman Hospital, Newcastle upon Tyne

PE8 6PL

Wansford and Kings Cliffe Practice, Petereborough

BA11 1EZ

Frome Medical Practice, Somerset

CV9 1EU

Dr. Trevor Gooding, Warwick Shire

CV32 4RA

Sherbourne Medical Centre, Warwickshire

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00739635 - Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus | Biotech Hunter | Biotech Hunter